Summit Partners Public Asset Management, LLC Axonics, Inc. Transaction History

Summit Partners Public Asset Management, LLC

$2.79 Billion
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$50.01 - $73.35 $6.37 Million - $9.34 Million	-127,391 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$59.21 - $78.66 $1.92 Million - $2.55 Million	-32,481 Reduced 20.32%	127,391 $8.29 Million
Q2 2021 Aug 16, 2021	BUY	$51.39 - $66.9 $8.22 Million - $10.7 Million	159,872 New	159,872 $10.1 Million

Others Institutions Holding AXNX

# of Institutions

234

Shares Held

42.1M

Call Options Held

83.4K

Put Options Held

65.3K

Vanguard Group Inc Valley Forge, PA

5.06M
Shares

$359 Million
0.01% of portfolio
Black Rock Inc. New York, NY

4.34M
Shares

$308 Million
0.01% of portfolio
Alpine Associates Management Inc. Englewood Cliffs, NJ

2.18M
Shares

$155 Million
6.99% of portfolio
Fil LTD Hamilton, D0

2.04M
Shares

$145 Million
0.14% of portfolio
Westchester Capital Management, LLC Valhalla, NY

1.45M
Shares

$103 Million
4.89% of portfolio

View Full List

About Axonics, Inc.

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

More about AXNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Partners Public Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit Partners Public Asset Management, LLC with notifications on news.

Account